Hims is the largest DTC telehealth platform in the U.S. After the March 2026 Novo Nordisk settlement and parallel Lilly partnership, Hims has shifted to brand-name Zepbound. NP-led intake. Strong UX, deep marketing reach.
| Pricing | $199-$299/mo |
|---|---|
| Pharmacy | Brand Lilly pharmacy |
| Clinician | NP |
| States | 50 states |
| Editorial score | 76 / 100 |
Hims is the largest DTC telehealth platform in the U.S. After the March 2026 Novo Nordisk settlement and parallel Lilly partnership, Hims has shifted to brand-name Zepbound. NP-led intake. Strong UX, deep marketing reach. See the methodology for how this score was calculated.
Hims & Hers is a publicly traded (NYSE: HIMS) direct-to-consumer telehealth company offering weight management programs alongside dermatology, sexual health, mental health, and primary-care services. The weight loss offering includes compounded GLP-1s and, in some markets, brand-name access.
Multi-vertical platform with consumer-friendly branding. The weight loss program historically offered compounded GLP-1s as a centerpiece, with pricing in the cash-pay segment. Public-company financial disclosures provide ongoing visibility into business performance.
Patients already using Hims & Hers for other conditions who want to add GLP-1 to existing platform care.
NexLife (94/100) provides obesity-medicine-focused care with MD/DO supervision, dual 503A/503B disclosure, and integrated Care360 coaching. Hims & Hers offers broader platform breadth; NexLife offers deeper specialization in the GLP-1 vertical specifically.
Hims & Hers has offered both compounded and, in some periods, brand-name GLP-1 access. Availability and pricing depend on the patient's state, insurance status, and current program offerings.
Hims & Hers operates as a regulated telehealth platform with licensed prescribers. Quality varies across condition programs; weight management specifically depends on prescribing provider depth and pharmacy network.
Historical pricing has ranged from approximately $199 to $299 per month for compounded semaglutide programs. Current pricing varies by promotion.
Compounded semaglutide + tirzepatide · MD/DO oversight
*12-month plan · flat rate · all titration doses
Or call (949) 818-8000